nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0757	0.132	CbGbCtD
Cabazitaxel—ABCG2—Dactinomycin—uterine cancer	0.0746	0.13	CbGbCtD
Cabazitaxel—CYP3A5—Progesterone—uterine cancer	0.0521	0.0911	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—uterine cancer	0.0502	0.0877	CbGbCtD
Cabazitaxel—CYP2C8—Progesterone—uterine cancer	0.0501	0.0876	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—uterine cancer	0.0421	0.0736	CbGbCtD
Cabazitaxel—ABCB1—Progesterone—uterine cancer	0.0339	0.0593	CbGbCtD
Cabazitaxel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0307	0.0537	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—uterine cancer	0.0287	0.0502	CbGbCtD
Cabazitaxel—ABCB1—Dactinomycin—uterine cancer	0.0269	0.047	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—uterine cancer	0.0233	0.0408	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—uterine cancer	0.0224	0.0392	CbGbCtD
Cabazitaxel—CYP3A4—Progesterone—uterine cancer	0.0203	0.0355	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—uterine cancer	0.0152	0.0265	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—uterine cancer	0.0104	0.0181	CbGbCtD
Cabazitaxel—CYP3A4—Etoposide—uterine cancer	0.0091	0.0159	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—uterine cancer	0.0062	0.0108	CbGbCtD
Cabazitaxel—TUBB4B—oviduct—uterine cancer	0.00491	0.0407	CbGeAlD
Cabazitaxel—TUBA4A—myometrium—uterine cancer	0.00251	0.0208	CbGeAlD
Cabazitaxel—Paclitaxel—CYP19A1—uterine cancer	0.00246	1	CrCbGaD
Cabazitaxel—TUBB1—decidua—uterine cancer	0.0024	0.0199	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—uterine cancer	0.00197	0.0163	CbGeAlD
Cabazitaxel—TUBA4A—uterine cervix—uterine cancer	0.00195	0.0162	CbGeAlD
Cabazitaxel—TUBB2B—myometrium—uterine cancer	0.00194	0.0161	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—uterine cancer	0.0019	0.0157	CbGeAlD
Cabazitaxel—TUBA4A—decidua—uterine cancer	0.00186	0.0154	CbGeAlD
Cabazitaxel—TUBB—myometrium—uterine cancer	0.00184	0.0153	CbGeAlD
Cabazitaxel—TUBB2A—myometrium—uterine cancer	0.00183	0.0152	CbGeAlD
Cabazitaxel—TUBA4A—renal system—uterine cancer	0.00183	0.0152	CbGeAlD
Cabazitaxel—TUBB6—myometrium—uterine cancer	0.00181	0.015	CbGeAlD
Cabazitaxel—TUBA4A—endometrium—uterine cancer	0.00177	0.0146	CbGeAlD
Cabazitaxel—TUBA4A—mammalian vulva—uterine cancer	0.00171	0.0142	CbGeAlD
Cabazitaxel—TUBA4A—uterus—uterine cancer	0.00163	0.0135	CbGeAlD
Cabazitaxel—TUBB4B—myometrium—uterine cancer	0.00157	0.013	CbGeAlD
Cabazitaxel—TUBB4A—uterine cervix—uterine cancer	0.00157	0.013	CbGeAlD
Cabazitaxel—SLCO1B3—vagina—uterine cancer	0.00153	0.0127	CbGeAlD
Cabazitaxel—TUBB2B—uterine cervix—uterine cancer	0.00151	0.0125	CbGeAlD
Cabazitaxel—TUBB4A—renal system—uterine cancer	0.00146	0.0121	CbGeAlD
Cabazitaxel—TUBA4A—female reproductive system—uterine cancer	0.00146	0.0121	CbGeAlD
Cabazitaxel—TUBB—uterine cervix—uterine cancer	0.00143	0.0119	CbGeAlD
Cabazitaxel—TUBB2A—uterine cervix—uterine cancer	0.00142	0.0118	CbGeAlD
Cabazitaxel—TUBB6—epithelium—uterine cancer	0.00142	0.0117	CbGeAlD
Cabazitaxel—TUBB2B—renal system—uterine cancer	0.00142	0.0117	CbGeAlD
Cabazitaxel—TUBB6—uterine cervix—uterine cancer	0.00141	0.0116	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—uterine cancer	0.00139	0.0115	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—uterine cancer	0.00138	0.0115	CbGeAlD
Cabazitaxel—TUBB2B—endometrium—uterine cancer	0.00137	0.0113	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—uterine cancer	0.00137	0.0113	CbGeAlD
Cabazitaxel—TUBB—decidua—uterine cancer	0.00136	0.0113	CbGeAlD
Cabazitaxel—TUBB2A—decidua—uterine cancer	0.00136	0.0113	CbGeAlD
Cabazitaxel—TUBB6—decidua—uterine cancer	0.00134	0.0111	CbGeAlD
Cabazitaxel—TUBA4A—female gonad—uterine cancer	0.00133	0.011	CbGeAlD
Cabazitaxel—TUBB2B—mammalian vulva—uterine cancer	0.00132	0.011	CbGeAlD
Cabazitaxel—TUBA4A—vagina—uterine cancer	0.00132	0.011	CbGeAlD
Cabazitaxel—TUBB6—renal system—uterine cancer	0.00131	0.0109	CbGeAlD
Cabazitaxel—TUBB4A—uterus—uterine cancer	0.00131	0.0108	CbGeAlD
Cabazitaxel—TUBB—endometrium—uterine cancer	0.0013	0.0107	CbGeAlD
Cabazitaxel—TUBB2A—endometrium—uterine cancer	0.00129	0.0107	CbGeAlD
Cabazitaxel—TUBB6—endometrium—uterine cancer	0.00127	0.0105	CbGeAlD
Cabazitaxel—TUBB—mammalian vulva—uterine cancer	0.00125	0.0104	CbGeAlD
Cabazitaxel—TUBB2A—mammalian vulva—uterine cancer	0.00125	0.0103	CbGeAlD
Cabazitaxel—TUBB6—mammalian vulva—uterine cancer	0.00123	0.0102	CbGeAlD
Cabazitaxel—TUBB4B—uterine cervix—uterine cancer	0.00122	0.0101	CbGeAlD
Cabazitaxel—SLCO1B1—renal system—uterine cancer	0.00122	0.0101	CbGeAlD
Cabazitaxel—TUBB—uterus—uterine cancer	0.00119	0.00989	CbGeAlD
Cabazitaxel—TUBB2A—uterus—uterine cancer	0.00119	0.00984	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—uterine cancer	0.00119	0.00984	CbGeAlD
Cabazitaxel—TUBB4A—female reproductive system—uterine cancer	0.00117	0.00972	CbGeAlD
Cabazitaxel—TUBB6—uterus—uterine cancer	0.00117	0.00971	CbGeAlD
Cabazitaxel—TUBB4B—decidua—uterine cancer	0.00116	0.00965	CbGeAlD
Cabazitaxel—TUBB4B—renal system—uterine cancer	0.00114	0.00947	CbGeAlD
Cabazitaxel—TUBB2B—female reproductive system—uterine cancer	0.00113	0.0094	CbGeAlD
Cabazitaxel—TUBB4B—endometrium—uterine cancer	0.0011	0.00916	CbGeAlD
Cabazitaxel—TUBB4B—mammalian vulva—uterine cancer	0.00107	0.00886	CbGeAlD
Cabazitaxel—TUBB4A—female gonad—uterine cancer	0.00107	0.00885	CbGeAlD
Cabazitaxel—TUBB2A—female reproductive system—uterine cancer	0.00107	0.00885	CbGeAlD
Cabazitaxel—TUBB6—female reproductive system—uterine cancer	0.00105	0.00873	CbGeAlD
Cabazitaxel—TUBB2B—female gonad—uterine cancer	0.00103	0.00855	CbGeAlD
Cabazitaxel—TUBB2B—vagina—uterine cancer	0.00103	0.0085	CbGeAlD
Cabazitaxel—TUBB4B—uterus—uterine cancer	0.00102	0.00844	CbGeAlD
Cabazitaxel—TUBB—female gonad—uterine cancer	0.000976	0.00809	CbGeAlD
Cabazitaxel—SLCO1B1—female reproductive system—uterine cancer	0.000976	0.00809	CbGeAlD
Cabazitaxel—TUBB2A—female gonad—uterine cancer	0.000971	0.00805	CbGeAlD
Cabazitaxel—TUBB—vagina—uterine cancer	0.00097	0.00804	CbGeAlD
Cabazitaxel—TUBB2A—vagina—uterine cancer	0.000965	0.008	CbGeAlD
Cabazitaxel—TUBB6—female gonad—uterine cancer	0.000958	0.00794	CbGeAlD
Cabazitaxel—TUBB6—vagina—uterine cancer	0.000952	0.00789	CbGeAlD
Cabazitaxel—ABCG2—myometrium—uterine cancer	0.000926	0.00767	CbGeAlD
Cabazitaxel—TUBB4B—female reproductive system—uterine cancer	0.000915	0.00758	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—uterine cancer	0.000856	0.0071	CbGeAlD
Cabazitaxel—TUBB4B—female gonad—uterine cancer	0.000833	0.0069	CbGeAlD
Cabazitaxel—TUBB4B—vagina—uterine cancer	0.000828	0.00686	CbGeAlD
Cabazitaxel—ABCG2—uterine cervix—uterine cancer	0.00072	0.00597	CbGeAlD
Cabazitaxel—CYP2C8—renal system—uterine cancer	0.000693	0.00574	CbGeAlD
Cabazitaxel—ABCG2—decidua—uterine cancer	0.000686	0.00569	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—uterine cancer	0.000686	0.00569	CbGeAlD
Cabazitaxel—CYP2C8—endometrium—uterine cancer	0.00067	0.00555	CbGeAlD
Cabazitaxel—CYP3A5—uterine cervix—uterine cancer	0.000669	0.00554	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—uterine cancer	0.000663	0.0055	CbGeAlD
Cabazitaxel—ABCG2—endometrium—uterine cancer	0.000652	0.0054	CbGeAlD
Cabazitaxel—ABCG2—mammalian vulva—uterine cancer	0.00063	0.00522	CbGeAlD
Cabazitaxel—TUBB—lymph node—uterine cancer	0.000628	0.0052	CbGeAlD
Cabazitaxel—CYP3A5—renal system—uterine cancer	0.000626	0.00519	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—uterine cancer	0.000624	0.00518	CbGeAlD
Cabazitaxel—TUBB6—lymph node—uterine cancer	0.000616	0.0051	CbGeAlD
Cabazitaxel—ABCG2—uterus—uterine cancer	0.0006	0.00498	CbGeAlD
Cabazitaxel—CYP2C8—female reproductive system—uterine cancer	0.000555	0.0046	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—uterine cancer	0.000535	0.00444	CbGeAlD
Cabazitaxel—CYP2C8—vagina—uterine cancer	0.000502	0.00416	CbGeAlD
Cabazitaxel—ABCG2—female gonad—uterine cancer	0.000491	0.00407	CbGeAlD
Cabazitaxel—ABCG2—vagina—uterine cancer	0.000488	0.00405	CbGeAlD
Cabazitaxel—CYP3A4—renal system—uterine cancer	0.000469	0.00389	CbGeAlD
Cabazitaxel—ABCB1—myometrium—uterine cancer	0.000456	0.00378	CbGeAlD
Cabazitaxel—CYP3A5—female gonad—uterine cancer	0.000456	0.00378	CbGeAlD
Cabazitaxel—CYP3A5—vagina—uterine cancer	0.000453	0.00376	CbGeAlD
Cabazitaxel—CYP3A4—female reproductive system—uterine cancer	0.000376	0.00312	CbGeAlD
Cabazitaxel—ABCB1—epithelium—uterine cancer	0.000358	0.00297	CbGeAlD
Cabazitaxel—ABCB1—uterine cervix—uterine cancer	0.000355	0.00294	CbGeAlD
Cabazitaxel—ABCB1—decidua—uterine cancer	0.000338	0.00281	CbGeAlD
Cabazitaxel—ABCB1—renal system—uterine cancer	0.000332	0.00275	CbGeAlD
Cabazitaxel—ABCB1—endometrium—uterine cancer	0.000321	0.00266	CbGeAlD
Cabazitaxel—ABCG2—lymph node—uterine cancer	0.000316	0.00262	CbGeAlD
Cabazitaxel—ABCB1—mammalian vulva—uterine cancer	0.000311	0.00258	CbGeAlD
Cabazitaxel—Headache—Progesterone—uterine cancer	0.000299	0.00138	CcSEcCtD
Cabazitaxel—Hot flush—Epirubicin—uterine cancer	0.000298	0.00137	CcSEcCtD
Cabazitaxel—ABCB1—uterus—uterine cancer	0.000296	0.00245	CbGeAlD
Cabazitaxel—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000296	0.00137	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Epirubicin—uterine cancer	0.000295	0.00136	CcSEcCtD
Cabazitaxel—Decreased appetite—Dactinomycin—uterine cancer	0.000293	0.00135	CcSEcCtD
Cabazitaxel—Dysgeusia—Etoposide—uterine cancer	0.000293	0.00135	CcSEcCtD
Cabazitaxel—Fatigue—Dactinomycin—uterine cancer	0.000291	0.00134	CcSEcCtD
Cabazitaxel—Back pain—Etoposide—uterine cancer	0.000289	0.00134	CcSEcCtD
Cabazitaxel—Pain—Dactinomycin—uterine cancer	0.000288	0.00133	CcSEcCtD
Cabazitaxel—Muscle spasms—Etoposide—uterine cancer	0.000288	0.00133	CcSEcCtD
Cabazitaxel—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.00132	CcSEcCtD
Cabazitaxel—Cardiac failure—Epirubicin—uterine cancer	0.000285	0.00132	CcSEcCtD
Cabazitaxel—Lethargy—Epirubicin—uterine cancer	0.000284	0.00131	CcSEcCtD
Cabazitaxel—Nausea—Progesterone—uterine cancer	0.000283	0.00131	CcSEcCtD
Cabazitaxel—Renal failure acute—Doxorubicin—uterine cancer	0.000279	0.00129	CcSEcCtD
Cabazitaxel—Pain in extremity—Epirubicin—uterine cancer	0.000278	0.00129	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000278	0.00129	CcSEcCtD
Cabazitaxel—Feeling abnormal—Dactinomycin—uterine cancer	0.000278	0.00128	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Etoposide—uterine cancer	0.000277	0.00128	CcSEcCtD
Cabazitaxel—Anaemia—Etoposide—uterine cancer	0.000276	0.00128	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000276	0.00127	CcSEcCtD
Cabazitaxel—Hot flush—Doxorubicin—uterine cancer	0.000275	0.00127	CcSEcCtD
Cabazitaxel—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000275	0.00127	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Doxorubicin—uterine cancer	0.000273	0.00126	CcSEcCtD
Cabazitaxel—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000271	0.00125	CcSEcCtD
Cabazitaxel—Malaise—Etoposide—uterine cancer	0.00027	0.00125	CcSEcCtD
Cabazitaxel—Vertigo—Etoposide—uterine cancer	0.000269	0.00124	CcSEcCtD
Cabazitaxel—Leukopenia—Etoposide—uterine cancer	0.000268	0.00124	CcSEcCtD
Cabazitaxel—Body temperature increased—Dactinomycin—uterine cancer	0.000267	0.00123	CcSEcCtD
Cabazitaxel—Abdominal pain—Dactinomycin—uterine cancer	0.000267	0.00123	CcSEcCtD
Cabazitaxel—ABCB1—female reproductive system—uterine cancer	0.000266	0.00221	CbGeAlD
Cabazitaxel—Cardiac arrest—Epirubicin—uterine cancer	0.000265	0.00122	CcSEcCtD
Cabazitaxel—Cardiac failure—Doxorubicin—uterine cancer	0.000264	0.00122	CcSEcCtD
Cabazitaxel—Lethargy—Doxorubicin—uterine cancer	0.000263	0.00121	CcSEcCtD
Cabazitaxel—Cough—Etoposide—uterine cancer	0.000261	0.00121	CcSEcCtD
Cabazitaxel—Dehydration—Epirubicin—uterine cancer	0.000259	0.0012	CcSEcCtD
Cabazitaxel—Hypertension—Etoposide—uterine cancer	0.000258	0.00119	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000258	0.00119	CcSEcCtD
Cabazitaxel—Pain in extremity—Doxorubicin—uterine cancer	0.000258	0.00119	CcSEcCtD
Cabazitaxel—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000257	0.00119	CcSEcCtD
Cabazitaxel—Dry skin—Epirubicin—uterine cancer	0.000255	0.00118	CcSEcCtD
Cabazitaxel—Chest pain—Etoposide—uterine cancer	0.000255	0.00118	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Epirubicin—uterine cancer	0.000254	0.00117	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Epirubicin—uterine cancer	0.000254	0.00117	CcSEcCtD
Cabazitaxel—Hypokalaemia—Epirubicin—uterine cancer	0.000253	0.00117	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000253	0.00117	CcSEcCtD
Cabazitaxel—Discomfort—Etoposide—uterine cancer	0.000252	0.00116	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—uterine cancer	0.000252	0.00116	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000251	0.00116	CcSEcCtD
Cabazitaxel—Hypersensitivity—Dactinomycin—uterine cancer	0.000248	0.00115	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—uterine cancer	0.000246	0.00114	CcSEcCtD
Cabazitaxel—Confusional state—Etoposide—uterine cancer	0.000246	0.00114	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000246	0.00113	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—uterine cancer	0.000245	0.00113	CcSEcCtD
Cabazitaxel—Infection—Etoposide—uterine cancer	0.000242	0.00112	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—uterine cancer	0.000242	0.00112	CcSEcCtD
Cabazitaxel—ABCB1—female gonad—uterine cancer	0.000242	0.00201	CbGeAlD
Cabazitaxel—Asthenia—Dactinomycin—uterine cancer	0.000242	0.00112	CcSEcCtD
Cabazitaxel—ABCB1—vagina—uterine cancer	0.000241	0.002	CbGeAlD
Cabazitaxel—Influenza—Epirubicin—uterine cancer	0.000241	0.00111	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—uterine cancer	0.00024	0.00111	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Etoposide—uterine cancer	0.000239	0.0011	CcSEcCtD
Cabazitaxel—Tachycardia—Etoposide—uterine cancer	0.000238	0.0011	CcSEcCtD
Cabazitaxel—Skin disorder—Etoposide—uterine cancer	0.000237	0.00109	CcSEcCtD
Cabazitaxel—Dry skin—Doxorubicin—uterine cancer	0.000236	0.00109	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000235	0.00109	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—uterine cancer	0.000235	0.00109	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—uterine cancer	0.000234	0.00108	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—uterine cancer	0.000233	0.00107	CcSEcCtD
Cabazitaxel—Anorexia—Etoposide—uterine cancer	0.000233	0.00107	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000232	0.00107	CcSEcCtD
Cabazitaxel—Diarrhoea—Dactinomycin—uterine cancer	0.000231	0.00107	CcSEcCtD
Cabazitaxel—Hypotension—Etoposide—uterine cancer	0.000228	0.00105	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—uterine cancer	0.000228	0.00105	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000227	0.00105	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—uterine cancer	0.000225	0.00104	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—uterine cancer	0.000225	0.00104	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—uterine cancer	0.000224	0.00103	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000224	0.00103	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—uterine cancer	0.000223	0.00103	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—uterine cancer	0.000222	0.00103	CcSEcCtD
Cabazitaxel—Paraesthesia—Etoposide—uterine cancer	0.000219	0.00101	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—uterine cancer	0.000218	0.00101	CcSEcCtD
Cabazitaxel—Dyspnoea—Etoposide—uterine cancer	0.000218	0.001	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—uterine cancer	0.000217	0.001	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—uterine cancer	0.000216	0.000996	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—uterine cancer	0.000215	0.000991	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—uterine cancer	0.000215	0.000991	CcSEcCtD
Cabazitaxel—Vomiting—Dactinomycin—uterine cancer	0.000214	0.00099	CcSEcCtD
Cabazitaxel—Decreased appetite—Etoposide—uterine cancer	0.000212	0.00098	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—uterine cancer	0.000211	0.000974	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Etoposide—uterine cancer	0.000211	0.000973	CcSEcCtD
Cabazitaxel—Fatigue—Etoposide—uterine cancer	0.00021	0.000972	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—uterine cancer	0.00021	0.000971	CcSEcCtD
Cabazitaxel—Constipation—Etoposide—uterine cancer	0.000209	0.000964	CcSEcCtD
Cabazitaxel—Pain—Etoposide—uterine cancer	0.000209	0.000964	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—uterine cancer	0.000209	0.000963	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—uterine cancer	0.000209	0.000963	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—uterine cancer	0.000208	0.000961	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—uterine cancer	0.000208	0.000961	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000207	0.000955	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—uterine cancer	0.000206	0.00095	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—uterine cancer	0.000205	0.000945	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—uterine cancer	0.000201	0.00093	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—uterine cancer	0.000201	0.000929	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—uterine cancer	0.000201	0.000927	CcSEcCtD
Cabazitaxel—Nausea—Dactinomycin—uterine cancer	0.0002	0.000925	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—uterine cancer	0.0002	0.000922	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—uterine cancer	0.0002	0.000922	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—uterine cancer	0.000198	0.000917	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—uterine cancer	0.000198	0.000917	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—uterine cancer	0.000195	0.000901	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000195	0.000899	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—uterine cancer	0.000193	0.000891	CcSEcCtD
Cabazitaxel—Body temperature increased—Etoposide—uterine cancer	0.000193	0.000891	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—uterine cancer	0.000193	0.000891	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—uterine cancer	0.000193	0.000891	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—uterine cancer	0.000192	0.000885	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—uterine cancer	0.00019	0.000878	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—uterine cancer	0.00019	0.000876	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—uterine cancer	0.000189	0.000874	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—uterine cancer	0.000189	0.000874	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—uterine cancer	0.000189	0.000872	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—uterine cancer	0.00018	0.000831	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—uterine cancer	0.00018	0.00083	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—uterine cancer	0.00018	0.000829	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—uterine cancer	0.000179	0.000825	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—uterine cancer	0.000179	0.000825	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—uterine cancer	0.000177	0.000819	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—uterine cancer	0.000176	0.000813	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—uterine cancer	0.000176	0.000811	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—uterine cancer	0.000175	0.000809	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—uterine cancer	0.000175	0.000809	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—uterine cancer	0.000175	0.000807	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—uterine cancer	0.000175	0.000807	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—uterine cancer	0.000174	0.000803	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—uterine cancer	0.000174	0.000801	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—uterine cancer	0.000173	0.000798	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—uterine cancer	0.000172	0.000794	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—uterine cancer	0.00017	0.000786	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—uterine cancer	0.000169	0.000779	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—uterine cancer	0.000168	0.000774	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—uterine cancer	0.000168	0.000774	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—uterine cancer	0.000167	0.000771	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—uterine cancer	0.000167	0.000769	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—uterine cancer	0.000166	0.000767	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—uterine cancer	0.000165	0.000764	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—uterine cancer	0.000165	0.000764	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—uterine cancer	0.000164	0.000758	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—uterine cancer	0.000162	0.000749	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—uterine cancer	0.000162	0.000747	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—uterine cancer	0.000161	0.000745	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—uterine cancer	0.000161	0.000744	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—uterine cancer	0.000161	0.000743	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—uterine cancer	0.000161	0.000742	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—uterine cancer	0.00016	0.000738	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—uterine cancer	0.000159	0.000735	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—uterine cancer	0.000157	0.000727	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—uterine cancer	0.000156	0.000721	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—uterine cancer	0.000156	0.00129	CbGeAlD
Cabazitaxel—Ill-defined disorder—Epirubicin—uterine cancer	0.000156	0.000718	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—uterine cancer	0.000155	0.000717	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—uterine cancer	0.000155	0.000716	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—uterine cancer	0.000155	0.000716	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—uterine cancer	0.000155	0.000716	CcSEcCtD
Cabazitaxel—Headache—Etoposide—uterine cancer	0.000153	0.000706	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—uterine cancer	0.000152	0.000701	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—uterine cancer	0.000151	0.000698	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—uterine cancer	0.000151	0.000696	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—uterine cancer	0.00015	0.000693	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—uterine cancer	0.00015	0.000693	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—uterine cancer	0.000149	0.000689	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—uterine cancer	0.000146	0.000676	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—uterine cancer	0.000145	0.00067	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—uterine cancer	0.000145	0.000668	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—uterine cancer	0.000144	0.000665	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—uterine cancer	0.000143	0.000662	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—uterine cancer	0.000143	0.000659	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—uterine cancer	0.000143	0.000659	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—uterine cancer	0.000143	0.000659	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—uterine cancer	0.000142	0.000657	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000142	0.000655	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—uterine cancer	0.000141	0.000651	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—uterine cancer	0.00014	0.000646	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—uterine cancer	0.00014	0.000645	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—uterine cancer	0.000139	0.000644	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—uterine cancer	0.000139	0.000641	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—uterine cancer	0.000138	0.000637	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—uterine cancer	0.000137	0.000632	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—uterine cancer	0.000136	0.000628	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—uterine cancer	0.000135	0.000625	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—uterine cancer	0.000134	0.00062	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—uterine cancer	0.000134	0.000619	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—uterine cancer	0.000134	0.000618	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—uterine cancer	0.000134	0.000617	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—uterine cancer	0.000133	0.000614	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—uterine cancer	0.000132	0.00061	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—uterine cancer	0.000132	0.00061	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—uterine cancer	0.000132	0.00061	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—uterine cancer	0.000132	0.000608	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000131	0.000606	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—uterine cancer	0.00013	0.000603	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—uterine cancer	0.00013	0.000602	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—uterine cancer	0.000129	0.000596	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—uterine cancer	0.000128	0.00059	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—uterine cancer	0.000128	0.000589	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—uterine cancer	0.000127	0.000585	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—uterine cancer	0.000126	0.000581	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000125	0.000576	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—uterine cancer	0.000124	0.000573	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—uterine cancer	0.000124	0.000572	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—uterine cancer	0.000124	0.000571	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—uterine cancer	0.000123	0.000568	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—uterine cancer	0.000123	0.000567	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—uterine cancer	0.000122	0.000563	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—uterine cancer	0.000121	0.000557	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—uterine cancer	0.00012	0.000556	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—uterine cancer	0.000119	0.000549	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—uterine cancer	0.000118	0.000546	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000118	0.000545	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—uterine cancer	0.000118	0.000545	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—uterine cancer	0.000117	0.00054	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—uterine cancer	0.000117	0.00054	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000115	0.000533	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—uterine cancer	0.000114	0.000525	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—uterine cancer	0.000113	0.000521	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—uterine cancer	0.000113	0.000521	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—uterine cancer	0.000112	0.000517	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—uterine cancer	0.000111	0.000515	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—uterine cancer	0.00011	0.000508	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000109	0.000505	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—uterine cancer	0.000109	0.000504	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—uterine cancer	0.000108	0.0005	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—uterine cancer	0.000108	0.0005	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—uterine cancer	0.000108	0.000499	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—uterine cancer	0.000108	0.000499	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—uterine cancer	0.000104	0.000482	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000104	0.000478	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—uterine cancer	0.000101	0.000465	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—uterine cancer	0.0001	0.000462	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—uterine cancer	0.0001	0.000462	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—uterine cancer	9.82e-05	0.000453	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—uterine cancer	9.36e-05	0.000432	CcSEcCtD
Cabazitaxel—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	9.35e-05	0.00106	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Doxorubicin—uterine cancer	9.33e-05	0.000431	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	9.24e-05	0.00104	CbGpPWpGaD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.2e-05	0.00104	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.08e-05	0.00103	CbGpPWpGaD
Cabazitaxel—Asthenia—Doxorubicin—uterine cancer	9.08e-05	0.000419	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—uterine cancer	9.05e-05	0.000418	CcSEcCtD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.91e-05	0.00101	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.88e-05	0.001	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—FBXW7—uterine cancer	8.79e-05	0.000994	CbGpPWpGaD
Cabazitaxel—Vomiting—Epirubicin—uterine cancer	8.7e-05	0.000402	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—uterine cancer	8.66e-05	0.0004	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—BIRC5—uterine cancer	8.6e-05	0.000973	CbGpPWpGaD
Cabazitaxel—Headache—Epirubicin—uterine cancer	8.57e-05	0.000396	CcSEcCtD
Cabazitaxel—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	8.53e-05	0.000964	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2B—uterine cancer	8.45e-05	0.000956	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	8.41e-05	0.000951	CbGpPWpGaD
Cabazitaxel—Dizziness—Doxorubicin—uterine cancer	8.37e-05	0.000387	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN2B—uterine cancer	8.26e-05	0.000934	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.23e-05	0.000931	CbGpPWpGaD
Cabazitaxel—Nausea—Epirubicin—uterine cancer	8.13e-05	0.000375	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—uterine cancer	8.05e-05	0.000372	CcSEcCtD
Cabazitaxel—TUBB4B—Metabolism of proteins—FBXW7—uterine cancer	8.04e-05	0.000909	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	7.98e-05	0.000902	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—BIRC5—uterine cancer	7.97e-05	0.000902	CbGpPWpGaD
Cabazitaxel—Headache—Doxorubicin—uterine cancer	7.93e-05	0.000366	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	7.93e-05	0.000897	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN2B—uterine cancer	7.55e-05	0.000854	CbGpPWpGaD
Cabazitaxel—Nausea—Doxorubicin—uterine cancer	7.52e-05	0.000347	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	7.5e-05	0.000848	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.46e-05	0.000844	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKR1B1—uterine cancer	7.43e-05	0.00084	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—STAR—uterine cancer	7.43e-05	0.00084	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	7.38e-05	0.000835	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.35e-05	0.000831	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—BIRC5—uterine cancer	7.29e-05	0.000825	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	7.28e-05	0.000824	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—BIRC5—uterine cancer	7.13e-05	0.000806	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	7.03e-05	0.000795	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SRD5A2—uterine cancer	6.91e-05	0.000781	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NDUFB11—uterine cancer	6.91e-05	0.000781	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.71e-05	0.000759	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CDKN2A—uterine cancer	6.7e-05	0.000758	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	6.64e-05	0.000751	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—BIRC5—uterine cancer	6.52e-05	0.000737	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.52e-05	0.000737	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	6.52e-05	0.000737	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—AKT1—uterine cancer	6.48e-05	0.000733	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.44e-05	0.000729	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.44e-05	0.000729	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CCL2—uterine cancer	6.41e-05	0.000725	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NDUFB11—uterine cancer	6.39e-05	0.000723	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SRD5A2—uterine cancer	6.39e-05	0.000723	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—uterine cancer	6.38e-05	0.000721	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.33e-05	0.000716	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	6.17e-05	0.000698	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CDKN1B—uterine cancer	5.94e-05	0.000672	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.92e-05	0.000669	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—EP300—uterine cancer	5.83e-05	0.000659	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—POLD1—uterine cancer	5.83e-05	0.000659	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.72e-05	0.000647	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN2A—uterine cancer	5.7e-05	0.000645	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDKN1B—uterine cancer	5.65e-05	0.000639	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CXCL8—uterine cancer	5.57e-05	0.00063	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—EP300—uterine cancer	5.52e-05	0.000625	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	5.52e-05	0.000624	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CCL2—uterine cancer	5.5e-05	0.000622	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CCL2—uterine cancer	5.5e-05	0.000622	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKR1C1—uterine cancer	5.45e-05	0.000617	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.39e-05	0.000609	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.34e-05	0.000604	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.31e-05	0.000601	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CCL2—uterine cancer	5.31e-05	0.000601	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	5.3e-05	0.0006	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	5.28e-05	0.000597	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—uterine cancer	5.23e-05	0.000592	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	5.23e-05	0.000591	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—EP300—uterine cancer	5.21e-05	0.00059	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—uterine cancer	5.17e-05	0.000585	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CCL2—uterine cancer	5.14e-05	0.000582	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CXCL8—uterine cancer	5.07e-05	0.000573	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN1B—uterine cancer	5.05e-05	0.000571	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CCL2—uterine cancer	5.03e-05	0.000569	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.02e-05	0.000568	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—STAR—uterine cancer	4.99e-05	0.000565	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKR1B1—uterine cancer	4.99e-05	0.000565	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—EP300—uterine cancer	4.96e-05	0.000561	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.94e-05	0.000558	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—RRM2—uterine cancer	4.86e-05	0.00055	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—uterine cancer	4.83e-05	0.000546	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.73e-05	0.000535	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN2A—uterine cancer	4.72e-05	0.000534	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—DCN—uterine cancer	4.72e-05	0.000534	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	4.68e-05	0.000529	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CTNNB1—uterine cancer	4.68e-05	0.000529	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKR1B1—uterine cancer	4.62e-05	0.000523	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—STAR—uterine cancer	4.62e-05	0.000523	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SRD5A2—uterine cancer	4.58e-05	0.000518	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NDUFB11—uterine cancer	4.58e-05	0.000518	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—uterine cancer	4.53e-05	0.000512	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CCL2—uterine cancer	4.52e-05	0.000511	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—uterine cancer	4.45e-05	0.000503	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP11A1—uterine cancer	4.45e-05	0.000503	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—EP300—uterine cancer	4.43e-05	0.000501	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—uterine cancer	4.35e-05	0.000492	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—uterine cancer	4.35e-05	0.000492	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN2A—uterine cancer	4.32e-05	0.000489	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1B—uterine cancer	4.28e-05	0.000484	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—uterine cancer	4.2e-05	0.000475	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKR1C3—uterine cancer	4.2e-05	0.000475	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN1B—uterine cancer	4.18e-05	0.000473	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CCL2—uterine cancer	4.13e-05	0.000467	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—uterine cancer	4.11e-05	0.000465	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—uterine cancer	4.09e-05	0.000462	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—uterine cancer	4.07e-05	0.00046	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CTNNB1—uterine cancer	4.01e-05	0.000454	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CTNNB1—uterine cancer	4.01e-05	0.000454	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—uterine cancer	3.98e-05	0.00045	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.97e-05	0.000449	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.97e-05	0.000449	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.96e-05	0.000448	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—uterine cancer	3.95e-05	0.000447	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.95e-05	0.000447	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—POLD1—uterine cancer	3.92e-05	0.000443	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.91e-05	0.000442	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CTNNB1—uterine cancer	3.87e-05	0.000438	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.85e-05	0.000436	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1B—uterine cancer	3.83e-05	0.000433	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—uterine cancer	3.78e-05	0.000428	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—uterine cancer	3.76e-05	0.000425	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CTNNB1—uterine cancer	3.75e-05	0.000424	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—uterine cancer	3.73e-05	0.000422	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—EP300—uterine cancer	3.67e-05	0.000415	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CTNNB1—uterine cancer	3.67e-05	0.000415	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKR1C1—uterine cancer	3.66e-05	0.000414	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.64e-05	0.000412	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—POLD1—uterine cancer	3.63e-05	0.00041	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—uterine cancer	3.57e-05	0.000404	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NDUFB11—uterine cancer	3.46e-05	0.000391	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SRD5A2—uterine cancer	3.46e-05	0.000391	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKR1C1—uterine cancer	3.39e-05	0.000384	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—EP300—uterine cancer	3.36e-05	0.00038	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—uterine cancer	3.34e-05	0.000378	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.34e-05	0.000377	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—STAR—uterine cancer	3.31e-05	0.000375	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKR1B1—uterine cancer	3.31e-05	0.000375	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CTNNB1—uterine cancer	3.29e-05	0.000373	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—STK11—uterine cancer	3.27e-05	0.00037	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP19A1—uterine cancer	3.27e-05	0.00037	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—RRM2—uterine cancer	3.27e-05	0.000369	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—uterine cancer	3.27e-05	0.000369	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—uterine cancer	3.17e-05	0.000359	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—DCN—uterine cancer	3.17e-05	0.000359	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.07e-05	0.000347	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—RRM2—uterine cancer	3.02e-05	0.000342	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CTNNB1—uterine cancer	3.01e-05	0.000341	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.99e-05	0.000338	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—DCN—uterine cancer	2.94e-05	0.000332	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.93e-05	0.000331	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.9e-05	0.000328	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.87e-05	0.000324	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—STAR—uterine cancer	2.87e-05	0.000324	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.84e-05	0.000321	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.82e-05	0.000319	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP11A1—uterine cancer	2.77e-05	0.000313	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.69e-05	0.000304	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—uterine cancer	2.63e-05	0.000297	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKR1C3—uterine cancer	2.61e-05	0.000295	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—POLD1—uterine cancer	2.6e-05	0.000294	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.54e-05	0.000287	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKR1B1—uterine cancer	2.5e-05	0.000283	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—STAR—uterine cancer	2.5e-05	0.000283	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.47e-05	0.00028	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—MTHFR—uterine cancer	2.46e-05	0.000278	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.43e-05	0.000275	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—uterine cancer	2.4e-05	0.000272	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.36e-05	0.000267	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—POLD1—uterine cancer	2.25e-05	0.000255	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.23e-05	0.000253	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—STK11—uterine cancer	2.2e-05	0.000249	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP19A1—uterine cancer	2.2e-05	0.000249	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—RRM2—uterine cancer	2.17e-05	0.000245	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.17e-05	0.000245	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.13e-05	0.000241	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.13e-05	0.000241	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKR1C1—uterine cancer	2.11e-05	0.000238	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—DCN—uterine cancer	2.1e-05	0.000238	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.06e-05	0.000233	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—STK11—uterine cancer	2.04e-05	0.00023	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP19A1—uterine cancer	2.04e-05	0.00023	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.98e-05	0.000224	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.97e-05	0.000223	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—POLD1—uterine cancer	1.96e-05	0.000222	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.9e-05	0.000215	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—RRM2—uterine cancer	1.88e-05	0.000212	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.87e-05	0.000212	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKR1C1—uterine cancer	1.83e-05	0.000207	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—DCN—uterine cancer	1.82e-05	0.000206	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.74e-05	0.000197	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.72e-05	0.000194	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.69e-05	0.000191	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.65e-05	0.000187	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—RRM2—uterine cancer	1.64e-05	0.000185	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.62e-05	0.000183	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—DCN—uterine cancer	1.59e-05	0.00018	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—STAR—uterine cancer	1.54e-05	0.000174	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.54e-05	0.000174	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—uterine cancer	1.53e-05	0.000173	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP11A1—uterine cancer	1.5e-05	0.000169	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.46e-05	0.000165	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—STK11—uterine cancer	1.46e-05	0.000165	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.46e-05	0.000165	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.43e-05	0.000161	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKR1C3—uterine cancer	1.41e-05	0.00016	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—uterine cancer	1.37e-05	0.000155	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—uterine cancer	1.3e-05	0.000147	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.26e-05	0.000143	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—STK11—uterine cancer	1.26e-05	0.000143	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—POLD1—uterine cancer	1.21e-05	0.000137	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.19e-05	0.000134	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.13e-05	0.000128	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.13e-05	0.000128	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—STK11—uterine cancer	1.1e-05	0.000124	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.000124	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—uterine cancer	1.1e-05	0.000124	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RRM2—uterine cancer	1.01e-05	0.000114	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DCN—uterine cancer	9.78e-06	0.000111	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—uterine cancer	9.65e-06	0.000109	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—uterine cancer	9.49e-06	0.000107	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.21e-06	0.000104	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—uterine cancer	9.19e-06	0.000104	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—uterine cancer	8.76e-06	9.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.7e-06	9.84e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—uterine cancer	8.51e-06	9.62e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.36e-06	9.46e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—uterine cancer	8.27e-06	9.35e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—uterine cancer	8.11e-06	9.18e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—uterine cancer	7.88e-06	8.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—STK11—uterine cancer	6.78e-06	7.67e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.78e-06	7.67e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—uterine cancer	6.48e-06	7.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—uterine cancer	6.1e-06	6.89e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—uterine cancer	6e-06	6.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—uterine cancer	5.81e-06	6.57e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—uterine cancer	5.29e-06	5.99e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—uterine cancer	5.28e-06	5.97e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—uterine cancer	5.09e-06	5.76e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—uterine cancer	5.03e-06	5.69e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—uterine cancer	4.9e-06	5.54e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—uterine cancer	4.6e-06	5.2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—uterine cancer	4.39e-06	4.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—uterine cancer	4.3e-06	4.86e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.72e-06	4.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—uterine cancer	3.51e-06	3.97e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—uterine cancer	3.24e-06	3.67e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—uterine cancer	3.04e-06	3.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—uterine cancer	2.83e-06	3.2e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—uterine cancer	2.7e-06	3.06e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—uterine cancer	2.65e-06	3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—uterine cancer	2e-06	2.26e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—uterine cancer	1.63e-06	1.85e-05	CbGpPWpGaD
